Ambee Pharmaceuticals (DHA:AMBEEPHA) EBIT : BDT Mil (TTM As of . 20)

View and export this data going back to 2004. Start your Free Trial

What is Ambee Pharmaceuticals EBIT?

Ambee Pharmaceuticals's earnings before interest and taxes (EBIT) for the six months ended in . 20 was BDT0.00 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.

Ambee Pharmaceuticals EBIT Historical Data

The historical data trend for Ambee Pharmaceuticals's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ambee Pharmaceuticals EBIT Chart

Ambee Pharmaceuticals Annual Data

Trend

EBIT

Ambee Pharmaceuticals Semi-Annual Data

EBIT

Competitive Comparison of Ambee Pharmaceuticals's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Ambee Pharmaceuticals's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ambee Pharmaceuticals's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ambee Pharmaceuticals's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Ambee Pharmaceuticals's EV-to-EBIT falls into.

Ambee Pharmaceuticals EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT for the trailing twelve months (TTM) ended in . 20 was BDT Mil.

Ambee Pharmaceuticals (DHA:AMBEEPHA) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Ambee Pharmaceuticals's annualized ROC % for the quarter that ended in . 20 is calculated as:

	ROC % (Q: . 20 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: . 20 )	+	Invested Capital (Q: . 20 ))	/ count )
=	* ( 1 - % )	/	( (	+	)	/ )
=		/
=	%

where

Invested Capital

(Q: . 20 )

Total Assets

Accounts Payable & Accrued Expense

Excess Cash

Total Assets

Accounts Payable & Accrued Expense

( Cash, Cash Equivalents, Marketable Securities

max(0, Total Current Liabilities

Total Current Assets

Cash, Cash Equivalents, Marketable Securities

))

(

max(0,

))

Invested Capital

(Q: . 20 )

Total Assets

Accounts Payable & Accrued Expense

Excess Cash

Total Assets

Accounts Payable & Accrued Expense

( Cash, Cash Equivalents, Marketable Securities

max(0, Total Current Liabilities

Total Current Assets

Cash, Cash Equivalents, Marketable Securities

))

(

max(0,

))

Note: The Operating Income data used here is one times the annual (. 20) data.

2. Joel Greenblatt's definition of Return on Capital:

Ambee Pharmaceuticals's annualized ROC (Joel Greenblatt) % for the quarter that ended in . 20 is calculated as:

	ROC (Joel Greenblatt) %		(Q: . 20 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: . 20		Q: . 20
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=		/	( ( ( + max(, 0))	+	( + max(, 0)) )	/	)
=		/	( (	+	)	/	)
=		/
=	%

where Working Capital is:

	Working Capital		(Q: . 20 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(	+		+	)	-	(	+		+	)
=

	Working Capital		(Q: . 20 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(	+		+	)	-	(	+		+	)
=

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (. 20) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Ambee Pharmaceuticals's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: . 20 )
	=		/	0.000
	=	%

Ambee Pharmaceuticals EBIT Related Terms

Thank you for viewing the detailed overview of Ambee Pharmaceuticals's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Ambee Pharmaceuticals (DHA:AMBEEPHA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ambee Pharmaceuticals Plc (DHA:AMBEEPHA) » Definitions » EBIT

Traded in Other Exchanges

N/A

Address

184/1 Tejgaon Industrial Area, Dhaka, BGD, 1208

Website

https://www.ambeepharma.com

Ambee Pharmaceuticals Plc formerly Ambee Pharmaceuticals Ltd manufactures a wide range of pharmaceutical products in Bangladesh. It is engaged in the business of manufacturing drugs and medicine and sales. Its products are sold in the form of tablets, capsules, liquids, gels, and injectables.

Ambee Pharmaceuticals (DHA:AMBEEPHA) Headlines

No Headlines